CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Get instant access to a free live CRSP US Total Market streaming chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style, bar ...

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $51.19, demonstrating a -1.88% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.79%.

The largest transaction of the day was ARK’s acquisition of 102,806 shares of CRISPR Therapeutics AG (NASDAQ: CRSP ), valued at approximately $5.26 million. This purchase through the ARKK ETF reflects ...

In an industry often defined by hype and regulatory hurdles, Adia Nutrition is quietly stacking real-world wins. With insurance-backed treatments, national exposure, and a scalable model already in ...

Review the current CRISPR Therapeutics AG (CRSP:XNAS) dividend yield and history to decide if CRSP is the best investment for you.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...